Previous studies in CRC cells have already demonstrated a collaboration of ezrin with SMAD2/3 signaling in the induction of PLOD2 gene transcription that involves the TGF-β receptor pathway, a key regulator of the epithelial to mesenchymal transition (EMT) process [17,27]. The gene discussed is SMAD2; the disease is colorectal carcinoma.